Delivery Order SPE2DB22D1103-SPE2DB25FTBC3
Award Date
10/29/24
Potential Completion Date
10/30/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,939.11 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets with a completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,916.75, is for the delivery of Letrozole 2.5 mg tablets in 90-count packages. This is a firm fixed-price delivery order contract with an ultimate completion date of October 28, 2024. The contract was not designated under any set-aside program, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,489.40 firm fixed-price delivery order is for the supply of 90 tablets of the drug Letrozole 2.5 mg. The contract has an ultimate completion date of July 8, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,081.68 firm fixed price delivery order is for the supply of 90 tablets of the drug Letrozole 2.5mg. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,002.37 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets (30 count) to support military and government healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,006.84 firm fixed-price delivery order is for Letrozole 2.5 mg tablets, a medication used in the treatment of certain types of breast cancer. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $1,219.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,387.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Letrozole 2.5 mg tablets to the government. This delivery order contract is a firm fixed-price agreement with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used to treat breast cancer. The contract has a ceiling value of $4,467.20 and a performance period ending on July 14, 2025. It is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,318.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply 4566490525 - Letrozole 2.5 mg Tablets in 90-count packages. The award has an Ultimate Completion Date of November 20, 2024 and a Firm Fixed Price pricing type. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...